Exercise capacity in a child with McArdle disease

Journal of Child Neurology

Volumn 22, Issue 7, 2007, Pages 880-882

  Pérez, Margarita ^a   Maté Muñoz, José L ^a   Foster, Carl ^d   Rubio, Juan C ^b,e   Andreu, Antoni L ^c,e   Martén, Miguel A ^b,e   Arenas, Joaquín ^b,e   Lucia, Alejandro ^a  

^a UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d UNIVERSITY OF WISCONSIN LA CROSSE   (United States)

^e CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

Glycogenosis type V; Myophosphorylase; Neuromuscular disease; Peak oxygen uptake

Indexed keywords

CREATINE KINASE; MERCAPTOPURINE; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FEVER; GENETIC SCREENING; GLYCOGEN STORAGE DISEASE TYPE 5; HEMATURIA; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MALE; MUSCLE FATIGUE; MYALGIA; NEUROLOGIC EXAMINATION; OXYGEN CONSUMPTION; PATIENT MONITORING; PHYSICAL CAPACITY; PRIORITY JOURNAL; PROTEINURIA; RHABDOMYOLYSIS; SCHOOL CHILD; SPIROMETRY; SWIMMING; TREADMILL EXERCISE;

CASE-CONTROL STUDIES; CHILD; CREATINE KINASE; EXERCISE TEST; EXERCISE THERAPY; EXERCISE TOLERANCE; GLYCOGEN STORAGE DISEASE TYPE V; HUMANS; MALE; MATCHED-PAIR ANALYSIS; OXYGEN CONSUMPTION; REFERENCE VALUES;

EID: 34547910308     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073807304206     Document Type: Article

References (12)

1. Tsujino S., Shanske S., DiMauro S. Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle disease). N Engl J Med. 1993;329:241-245.
2. Pérez M., Morán M., Cardona C., et al. Can McArdle's patients run? Br J Sports Med. 2007;41:53-54.
3. Lucia A., Maté-Muñoz JL, Pérez M., Foster C., Gutiérrez-Rivas E., Arenas J. Double trouble (McArdle's disease and myasthenia gravis): How can exercise help? Muscle Nerve. 2006;35:125-128.
4. Haller RG, Wyrick P., Taivassalo T., Vissing J. Aerobic conditioning: An effective therapy in McArdle's disease. Ann Neurol. 2006;59:922-928.
5. Vissing J., Haller RG The effect of oral sucrose on exercise tolerance in patients with McArdle's disease. N Engl J Med. 2003;349:2503-2509.
6. Colomer Oferil J, Yoldi ME, Vila Torres J. Muscular phosphorylase deficiency in two siblings. An Esp Pediatr. 1990;32:154-158.
7. Kristjansson K., Tsujino S., DiMauro S. Myophosphorylase deficiency: An unusually severe form with myoglobinuria. J Pediatr. 1994;125:409-410.
8. López Martín A., Baños Madrid RI, García-Estañ Candela J., García Pérez B., Pérez Bautista FJ, Salmerón P. McArdle disease: Report of four brothers with myophosphorylase deficiency. An Med Interna. 2001;18:136-138.
9. Meyer T., Lucia A., Earnest CP, Kindermann W. A conceptual framework for performance diagnosis and training prescription from submaximal parameters-theory and application. Int J Sports Med 2005;(suppl1):S38-S48.
10. McArdle WD, Katch FI, Katch VL Exercise Physiology. Energy, Nutrition and Performance. 5 th ed. Philadelphia, Penn: Lippincott Williams & Wilkins; 2001:183.
11. Day JR, Rossiter HB, Coats EM, Skasick A., Whipp BJ The maximally-attainable VO2 during exercise in humans: The peak vs maximum issue. J Appl Physiol. 2003;95:1901-1907.
12. Myers J., Prakash M., Froelicher V., Do D., Partington S., Atwood JE Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346:793-801.